Causal relationship between gout and liver cancer: A Mendelian randomization and transcriptome analysis

Jiaqi Xi,Xiaofang Cheng,Jun Liu

DOI: https://doi.org/10.1097/md.0000000000040299

IF: 1.6

2024-11-13

Medicine

Abstract:Gout is an inflammatory arthritis caused by the deposition of urate crystals in different joints. [ 1 ] As the world economy progresses, the global incidence of gout has steadily increased to 7.9 per 1000 men and 2.5 per 1000 women. [ 2 ] Sodium urate crystal deposition due to hyperuricemia is now widely recognized as the cause of gout. [ 1 ] At the same time, increasing evidence suggests that gout is significantly associated with metabolic syndrome, with hyperuricemia playing an important role, which indicates that gout is also a metabolic disease. [ 3 ] Liver cancer is the sixth most common cancer in the world, with a 5-year survival rate of about 18%. [ 4 ] Viral hepatitis, alcoholic liver disease, and nonalcoholic fatty liver disease are important risk factors for liver cancer. Currently, nonalcoholic fatty liver disease is the leading cause of liver cancer in Western countries due to the increased prevalence rate of metabolic syndrome. [ 5 ] Notably, multiple observational studies have shown that hyperuricemia or gout is associated with higher cancer incidence as well as mortality. [ 6–10 ] In hepatocellular carcinoma, Guo et al [ 11 ] found that hyperuricemia may affect the expression of PDZK1. PDZK1 affects proliferation, migration, and apoptosis of hepatocellular carcinoma through the STAT3/C-myc pathway. This suggests a potential association between gout and hepatocellular carcinoma. Gout is a chronic disease that can be prevented and controlled; therefore, understanding the relationship between gout and cancer risk is essential for reducing cancer mortality. However, the causal relationship between gout and liver cancer remains uncertain.

medicine, general & internal